Why Are More International Brands Skipping Intermediaries and Partnering Directly with Chinese Peptide Factories?

The global peptide supply chain has undergone remarkable transformation in recent years. Numerous international beauty, health and pharmaceutical brands are restructuring their procurement models. They are gradually abandoning traditional multi-layered intermediary channels and choosing to cooperate directly with reliable Chinese peptide manufacturers. This growing industry trend is no coincidence. It stems from the comprehensive upgrading of China’s peptide industry in technology, production capacity and quality control, overturning long-standing stereotypes about domestic peptide products in the global market.

The Domestic Peptide Industry Is Flooded with Mixed-quality Manufacturers: How to Identify the True R&D Strength of Peptide Factories?

With the wide application of peptides in the beauty, health food and biomedical fields, the domestic peptide production industry has boomed rapidly. A large number of manufacturers of varying scales have entered the market, leading to uneven industry standards.

From Gram-scale R&D to Kilogram-scale Mass Production: How Leading Peptide Factories Achieve Cost-effective Supply of CU Peptide for Cosmetics

As a highly popular functional cosmetic peptide, CU Peptide is widely adopted in skincare formulas for its outstanding effects on skin repair, soothing stabilization and skin texture improvement. However, CU Peptide has long been plagued by high R&D barriers, difficult mass production and excessive manufacturing costs.